Skip to main navigation Skip to search Skip to main content

Prolongation of mouse and rat pancreatic islet cell allografts by adenosine deaminase inhibitors and adenine arabinoside

  • Caliann T. Lum
  • , David E R Sutherland
  • , William D. Payne
  • , Phyllis Gorecki
  • , Arthur J. Matas
  • , John S. Najarian

Research output: Contribution to journalArticlepeer-review

Abstract

Two adenosine deaminase inhibitors, erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA) and 2-deoxycoformycin (2dCF) were evaluated for immunosuppressive properties in mouse and rat pancreatic islet cell allograft models. In the mouse model, administration of EHNA alone prolonged the survival of islet allografts. In the rat, neither EHNA or 2dCF alone permitted islet allograft survival. However, 2dCF, in combination with the deoxyadenosine analog adenine arabinoside provided significant rat islet allograft survival during a limited 8-day period of study.

Original languageEnglish (US)
Pages (from-to)44-48
Number of pages5
JournalJournal of Surgical Research
Volume28
Issue number1
DOIs
StatePublished - Jan 1980

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Prolongation of mouse and rat pancreatic islet cell allografts by adenosine deaminase inhibitors and adenine arabinoside'. Together they form a unique fingerprint.

Cite this